Schade Christian S

CIK 0001214496

Chairman & CEODirector

Filings

Latest May 11, 2026

Issuers covered

Showing

13 of 13

Page 1

Track record

1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

Horizon	Trades	Win rate	Avg	Median	Best	Worst
30 days	1	100%	+28.0%	+28.0%	+28.0%	+28.0%
90 days	1	100%	+40.8%	+40.8%	+40.8%	+40.8%
180 days	1	0%	-28.0%	-28.0%	-28.0%	-28.0%
365 days	1	0%	-70.1%	-70.1%	-70.1%	-70.1%

Companies where Schade Christian S has filed

Ticker	Issuer	Filings	Last filed
IART	Integra Lifesciences Holdings Corp	5	May 11, 2026
APRE	Aprea Therapeutics, Inc.	4	Jun 7, 2022
OMGA	Omega Therapeutics, Inc.	4	Jun 21, 2024

13 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
May 11, 2026	IARTIntegra Lifesciences Holdings Corp	Holdings only	-	-	-
May 13, 2025	IARTIntegra Lifesciences Holdings Corp	AGrant	6,939	$0.00	$0
Jun 21, 2024	OMGAOmega Therapeutics, Inc.	Holdings only	-	-	-
May 13, 2024	IARTIntegra Lifesciences Holdings Corp	AGrant	8,696	$0.00	$0
Feb 9, 2024	OMGAOmega Therapeutics, Inc.	Holdings only	-	-	-
Feb 9, 2024	OMGAOmega Therapeutics, Inc.A	Holdings only	-	-	-
Jul 12, 2023	OMGAOmega Therapeutics, Inc.	Holdings only	-	-	-
May 16, 2023	IARTIntegra Lifesciences Holdings Corp	AGrant	4,486	$0.00	$0
Jun 7, 2022	APREAprea Therapeutics, Inc.	FTax	65,770	$0.805	$52,945
May 19, 2022	APREAprea Therapeutics, Inc.	PPurchase	37,500	$0.6433	$24,124
May 17, 2022	IARTIntegra Lifesciences Holdings Corp	AGrant	1,265	$0.00	$0
Mar 14, 2022	APREAprea Therapeutics, Inc.	AGrant	100,100	$0.00	$0
Mar 1, 2022	APREAprea Therapeutics, Inc.	FTax	21,644	$1.74	$37,661

Showing 1-13 of 13

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.